Alar Breaks Key Barriers in Ketamine Therapy with Positive Phase 1 Results for Long-Acting Injectable ALA-3000 for Treatment-Resistant Depression
By reducing dissociation and sedation risk, ALA-3000 may eliminate the ≥2-hour post-dose monitoring requirement, reducing clinic operating costs, improving patient throughput, and supporting a more cost-effective and reimbursement-aligned treatment...
Surging Demand for On-demand Delivery
SF Intra-city (09699.HK) Projects Sustained Healthy Growth in Full-year Revenue and Net Profit for 2025 HONG KONG, Feb. 3, 2026 /PRNewswire/ -- Hangzhou SF Intra-city Industrial Co., Ltd. ("SF Intra-city" or the "Group", Stock Code: 9699.HK),...
Emaar Contributed Over US$ 1 Billion to Elevate Dubai's Global Brand and Visitor Experience
Continued Annual Contributions of Over US$ 50 Million to Sustain and Modernise Globally Renowned Events and Attractions Strong Focus on Local Community Impact Through Community Initiatives and Sponsorships DUBAI, UAE, April 22, 2025 /PRNewswire/ --...